期刊文献+

PCNA在进展期胃癌中表达及与预后关系的研究

Proliferating Cell Nuclear Antigen in Advanced Gastric Cancers and Relationship with Prognosis
下载PDF
导出
摘要 目的 :用针对细胞增殖核抗原 (proliferatingcellnuclearantigen ,PCNA)的抗体检测进展期胃癌细胞的增殖活力 ,探讨其表达及与预后的关系。方法 :用免疫组织化学方法测定了 157例内窥镜活检标本和其中 10例手术切除标本及 10例正常胃粘膜标本的PCNA标记指数 (Lablingindex ,LI)。结果 :PC NA在肿瘤的增殖细胞和正常胃粘膜腺体颈部细胞的核内强染色。PCNALI正常胃粘膜为 3 5%~10 6% ( 6 5± 3 4 ) % ,胃癌活检组织 12 6%~ 68 0 % ( 34 2± 10 7) % ,P <0 0 1。在肝脏和淋巴结转移、浆膜侵犯、腹腔播散、肿瘤大于或等于 6cm和组织学分化差的胃癌PCNALI明显增高 (P <0 0 1)。高PCNALI(≥ 35% ) 5年生存率明显低于低PCNALI( <35% )者 (P <0 0 1)。结论 Objective:That proliferrative activity, as measured by using monoclonal antibody against proliferative cell nuclear antigen(PNCA), is used in advanced gastric cancers and relationship with prognosis.Methods:PCNA labeling index(LI) was quantified by immunohistochemistry on formalih fixed paraffin embedded biopsy or surgically resected specimens from 157 patients with advanced gastric cancer and from 10 normal gastic mucosa.Ruesults:Immunohistochemic analysis has demonstrated that PCNA reveals an intensive staining in the nuclear of tumor cell and mucosal neek cells of gastic glands. PCNA LI ranged from 3.5 to 10.6%(6 5+3 4)%,in normal gastic mucosa, 12.6%-68.0%(34.2±10.)7% in endoscopic biopsy of advanced gastric cancer(P<0.01). There was a siginficant correlation between PCNA LI of biopsy and that of resected specimens of gastic cancer(γ=0.970 2,P<0.01). PCNA LI was significantly higher(P<0 01) in slices of tissues from liver and lymphotic metastasis, scrosal invasion, peritoneal metastasis, tumor size≥6cm and histologically poorly differentiated tomors. The 5 Yr Survival rate of patients with high PCNA LI(≥35) was significantly poor(P<0.01)than those with low LI(<35%).Conclusins:When the PCNA LI and pathologic factors were analyzed by the Cox Regression Model, PCNA LI emerged as an important and independent prognostic indicator.
出处 《肿瘤防治杂志》 2000年第3期236-239,共4页 China Journal of Cancer Prevention and Treatment
关键词 胃肿瘤 增殖细胞核抗原 预后 免疫组织化学 stomach neoplasms proliferating cell nuclear antigen (PCNA) Prognosis Immunogistochemistry
  • 相关文献

参考文献12

  • 1 Quinn CM, WrightNA.The clinical assessmet of proliferation and growth in human tumours: Evaluation ofmethods and applications as prognotic variables[J].J Pathol,1996,160:93~97.
  • 2 Woosley JT.Measuring cell proliferation[J].Arch Pathol Lab Med,1996,115:555~559.
  • 3 Hedly DM. Flow cytometry usig paraffin embedded tissues: five years on[J].Cytometry,1997,10:229~236.
  • 4 Mccormick D,Yu C,Hobbs C,et al. The relevance of antibiily concentration to theimmnohistological quantification of cell proliferation-associated antigens[J].Histopathology,1996,22:543~547.
  • 5 Kimara H, Yonpmura Y, Epstein AL. Flow cytometric quantitation of theproliferationassociated nuclear antigen P105 and DNA content in advanced gastric cancers[J].Cancer,1997,68:2175~2178.
  • 6 Morris GF, Matheas MB. Reguoation of proliferating cell naclear antigen d-uringthe cell cycle[J].J Biol chem,1998,264:13856~13859.
  • 7 Moccmick D, Hall PA. The complexities of proliferating cell nuclear antig-en[J].Histopatholopy,1998,21:591~595.
  • 8 Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative activity using antiPCNA/Cylin monoclonal mtibodies in fixed, embedded trssues[J].AMJPathol,1997,134:733~736.
  • 9 Yonemura Y, Kimura H, Fushida S, et al. Analysis of proliferative activity usingantiproliferating cell nuclenr antigcn antibody in gastric cancer tissue specimensobtained by encoscopic biopsy[J].Cancer,1996,71:2448~2451.
  • 10 Weisgerber UM, Boeing H, Nemitz R, et al. Proliferation cell nuclearantig-en(clone 19 A2) correaltes with 5-bromo-2-deoxyuridine labelling in human colonicepitheium[J].Gut,1995,1587~1593.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部